Attributable burden in patients with carbapenem-nonsusceptible gram-negative respiratory infections.

Increased LOS and cost burden were observed in propensity score-matched patients with C-NS compared with C-S respiratory infections; the C-NS-attributable burden was significant only for patients with other principal diagnoses.